Table 2.
Measures from HEDIS | Use either HEDIS or HPA | Use neither HEDIS nor HPA | Comparison | |||||
---|---|---|---|---|---|---|---|---|
Mean % (SD) | 25th percentile | 75th percentile | Mean % (SD) | 25th percentile | 75th percentile | Mean difference | p-value | |
Vaccinations | ||||||||
HPV | 27.2 (8.5) | 21.7 | 30.5 | 29.1 (9.7) | 22.4 | 34.0 | −1.9 | 0.139 |
Meningococcal | 81.9 (9.3) | 76.7 | 88.8 | 77.0 (9.2) | 70.9 | 84.3 | 5.0 | <0.001 *** |
Tdap | 88.0 (7.5) | 85.9 | 93.2 | 85.4 (7.3) | 80.4 | 90.8 | 2.7 | 0.008 *** |
Access/utilization of preventive care | ||||||||
Well-care visits | 50.9 (12.1) | 42.8 | 58.2 | 45.4 (9.3) | 38.7 | 52.1 | 5.5 | <0.001 *** |
Access to PCP | 90.8 (4.5) | 88.4 | 93.8 | 89.4 (3.77) | 87.91 | 92.07 | 1.3 | 0.012 ** |
Number of states | 32 | — | — | 7 | — | — | — | — |
Number of companies | 292 | — | — | 63 | — | — | — | — |
Note: Boldface indicates statistical significance.
p<0.05,
p<0.01
The analysis included 39 states that have at least 70% of public reporting. The District of Columbia is not a U.S. state, but the term state is used for simplicity. States identified as using HEDIS or HPA (HEDIS/HPA) included Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia, and Wisconsin. States identified as not using HEDIS/HPA included Colorado, Delaware, District of Columbia, Idaho, Kansas, North Carolina, and Washington.
HEDIS, Health Effectiveness Data and Information Set; HPA, Health Plan Accreditation; HPV, human papillomavirus; PCP, primary care practitioner; Tdap, tetanus, diphtheria, and acellular pertussis vaccine.